Laboratory Apparatus And Analytical, Optical, Measuring, and Controlling Instruments - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the Laboratory industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

Laboratory Apparatus And Analytical, Optical, Measuring, and Controlling Instruments - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - Laboratory Apparatus And Analytical, Optical, Measuring, and Controlling Instruments
Corporate Insider Buy Sell Ratio (Insider Count) - Laboratory Apparatus And Analytical, Optical, Measuring, and Controlling Instruments
Laboratory Apparatus And Analytical, Optical, Measuring, and Controlling Instruments - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Security Form Insider Code 10b5-1 Direct Share
Price
Shares
Changed
2025-08-18 CTKB / Cytek Biosciences, Inc. 4 Jiang Wenbin M - Exercise D 29,002
2025-08-18 CTKB / Cytek Biosciences, Inc. 4 Busque Philippe M - Exercise D 2,210
2025-08-18 CTKB / Cytek Biosciences, Inc. 4 Yan Ming M - Exercise D 5,525
2025-08-18 CTKB / Cytek Biosciences, Inc. 4 Busque Philippe M - Exercise D 3,625
2025-08-18 CTKB / Cytek Biosciences, Inc. 4 Yan Ming M - Exercise D 7,363
2025-08-18 CTKB / Cytek Biosciences, Inc. 4 McCombe William D. M - Exercise D 13,051
2025-08-18 CTKB / Cytek Biosciences, Inc. 4 Jiang Wenbin M - Exercise D 6,758
2025-08-18 CTKB / Cytek Biosciences, Inc. 4 Barnett Valerie M - Exercise D 3,681
2025-08-18 MKSI / MKS Inc. 4 Schreiner James Alan M - Exercise D 2,641
2025-08-18 CTKB / Cytek Biosciences, Inc. 4 Barnett Valerie M - Exercise D 7,735
2025-08-18 CTKB / Cytek Biosciences, Inc. 4 Barnett Valerie M - Exercise D 2,016
2025-08-18 CTKB / Cytek Biosciences, Inc. 4 Jiang Wenbin M - Exercise D 22,100
2025-08-18 CTKB / Cytek Biosciences, Inc. 4 McCombe William D. F - Taxes D 4.06 -5,084
2025-08-18 CTKB / Cytek Biosciences, Inc. 4 Barnett Valerie F - Taxes D 4.06 -1,434
2025-08-18 CTKB / Cytek Biosciences, Inc. 4 Barnett Valerie F - Taxes D 4.06 -3,000
2025-08-18 CTKB / Cytek Biosciences, Inc. 4 Barnett Valerie F - Taxes D 4.06 -786
2025-08-18 MKSI / MKS Inc. 4 Schreiner James Alan F - Taxes D 100.22 -1,249
2025-08-18 CTKB / Cytek Biosciences, Inc. 4 Yan Ming F - Taxes D 4.06 -588
2025-08-18 CTKB / Cytek Biosciences, Inc. 4 Yan Ming F - Taxes D 4.06 -2,184
2025-08-18 CTKB / Cytek Biosciences, Inc. 4 Jiang Wenbin F - Taxes D 4.06 -7,062
2025-08-18 CTKB / Cytek Biosciences, Inc. 4 Jiang Wenbin F - Taxes D 4.06 -5,382
2025-08-18 CTKB / Cytek Biosciences, Inc. 4 Jiang Wenbin F - Taxes D 4.06 -2,869
2025-08-18 CTKB / Cytek Biosciences, Inc. 4 Yan Ming F - Taxes D 4.06 -1,498
2025-08-18 CTKB / Cytek Biosciences, Inc. 4 Yan Ming F - Taxes D 4.06 -1,468
2025-08-18 CTKB / Cytek Biosciences, Inc. 4 McCombe William D. F - Taxes D 4.06 -2,462
2025-08-18 CTKB / Cytek Biosciences, Inc. 4 Barnett Valerie F - Taxes D 4.06 -3,609
2025-08-18 CTKB / Cytek Biosciences, Inc. 4 Busque Philippe F - Taxes D 4.06 -1,412
2025-08-18 CTKB / Cytek Biosciences, Inc. 4 Busque Philippe F - Taxes D 4.06 -861
2025-08-18 CTKB / Cytek Biosciences, Inc. 4 Jiang Wenbin F - Taxes D 4.06 -1,646
2025-08-18 CTKB / Cytek Biosciences, Inc. 4 Busque Philippe F - Taxes D 4.06 -599
2025-08-18 AVTR / Avantor, Inc. 4 Ligner Emmanuel A - Award D 195,924
2025-08-15 ROP / Roper Technologies, Inc. 4 JOHNSON ROBERT D S - Sale D 529.15 -200
2025-08-15 FCUV / Focus Universal Inc. 4 WANG DESHENG P - Purchase D 2.20 1,000
2025-08-15 FCUV / Focus Universal Inc. 4 WANG DESHENG P - Purchase D 2.28 1,000
2025-08-15 FCUV / Focus Universal Inc. 4 WANG DESHENG P - Purchase D 2.23 1,000
2025-08-15 FCUV / Focus Universal Inc. 4 WANG DESHENG P - Purchase D 2.18 1,000
2025-08-15 FCUV / Focus Universal Inc. 4 WANG DESHENG P - Purchase D 2.20 1,000
2025-08-15 FCUV / Focus Universal Inc. 4 WANG DESHENG P - Purchase D 2.25 1,000
2025-08-15 FCUV / Focus Universal Inc. 4 WANG DESHENG P - Purchase D 2.28 1,000
2025-08-15 FCUV / Focus Universal Inc. 4 WANG DESHENG P - Purchase D 2.28 1,000
2025-08-15 FCUV / Focus Universal Inc. 4 WANG DESHENG P - Purchase D 2.22 1,000
2025-08-15 FCUV / Focus Universal Inc. 4 WANG DESHENG P - Purchase D 2.20 1,000
2025-08-15 FCUV / Focus Universal Inc. 4 WANG DESHENG P - Purchase D 2.22 1,000
2025-08-15 MLAB / Mesa Laboratories, Inc. 4 Hall Shannon M - Exercise D 1,404
2025-08-15 MLAB / Mesa Laboratories, Inc. 4 Sullivan John James M - Exercise D 1,404
2025-08-15 MLAB / Mesa Laboratories, Inc. 4 Alltoft Jennifer Sadie M - Exercise D 1,404
2025-08-15 MLAB / Mesa Laboratories, Inc. 4 Ladiwala Shiraz Shabanali M - Exercise D 1,949
2025-08-15 MLAB / Mesa Laboratories, Inc. 4 Tripeny R Tony M - Exercise D 1,404
2025-08-15 MLAB / Mesa Laboratories, Inc. 4 Capone Mark Christopher M - Exercise D 1,404
2025-08-15 MKSI / MKS Inc. 4 Williams John Edward M - Exercise D 947
P
Åpent marked eller private kjøp av ikke-derivat eller derivat sikkerhet.
S
Åpent marked eller private kjøp av ikke-derivat eller derivat sikkerhet.
A
Bevilgning, tildeling eller andre oppkjøp av verdipapirer fra selskapet (slik som en opsjon)
C
Konvertering av derivat
D
Salg eller overføring av verdipapirer tilbake til selskapet
F
Betaling av utøvelseskurs eller skatteplikt ved å bruke deler av verdipapirer mottat fra selskapet
G
Gave av verdipapirer fra eller til insidere
K
Aksjebytting og lignende sikringsavtaler
M
Øvelse eller konvertering av derivatverdipapir mottatt fra selskapet (for eksempel en opsjon)
V
En transaksjon frivilig rapportert på Skjema 4
J
Annet (med en fotnote som beskriver transaksjonen)